Gabrielle DeBartolomeo

First Name*

Last Name*

Email*

Phone*

Message*

I am authorized to claim this profile. I agree Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

First Name*

Last Name*

Email*

Phone*

Message*

Gabrielle DeBartolomeo and Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

Contact Gabrielle

Gabrielle DeBartolomeo

Clinical Trial Scientist

Alkeus Pharmaceuticals, Inc.

Gabrielle DeBartolomeo is the clinical trial scientist at Alkeus Pharmaceuticals, a Boston-based biotech focused on developing treatments for rare and common forms of currently untreatable blindness including age-related macular degeneration and Stargardt disease. Wearing multiple hats in the company, she is responsible for clinical operations activities and coordinates operational and regulatory activities with private practice and academic sites, in addition to leading patient outreach and support. Through this role, she has witnessed firsthand the multidimensional impact of COVID-19 on clinical trials.

Talks About
#pharma #medicine

Preferred Locations
#NorthAmerica

Speaking Engagements

Clinical Trials In Rare Diseases 2023

Paid

We are pleased to announce the launch of a brand new event: Clinical Trials in Rare Diseases will take place on 13th-14th September 2023 in Princeton!

This event will explore the challenges in clinical trials for orphan drugs and rare diseases, bringing together clinical operations professionals from across multiple therapeutic areas to

13-14 September 2023

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Gabrielle DeBartolomeo

Clinical Trial Scientist

Speaking Engagements

Clinical Trials In Rare Diseases 2023